More interestingly, we showed a positive linear correlation between serum IL-4 levels and the VAS for arthritis or the DAS28-ESR, and SSc patients with moderate–high joint involvement had statistically significantly higher serum IL-4 levels than SSc patients with a DAS28-ESR ≤ 3.2. This evidence concerns the gene IL4 and systemic sclerosis.